Clinical Trial Update: Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing immunogenicity and safety of concomitant administration of bivalent COVID-19 vaccines with influenza vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Response
• Safety

Snippet

Sponsor: Catholic Kwandong University | Conditions: Immune Response, Safety | Phase 4 | Status: COMPLETED